Evaluating High-Dose Rivastigmine Patch in Severe Alzheimer’s Disease: Analyses with Concomitant Memantine Usage as a Factor

By  

Current Alzheimer Research, Vol. 12, Iss. 1, 2015-01 ,pp. : 53-60

Bentham Science Publishers

Access to resources Recommend Favorite

Cognitive Training in Patients with Alzheimer's Disease: Findings of a 12-month Randomized Controlled Trial

By  

Current Alzheimer Research, Vol. 15, Iss. 5, 2018-03 ,pp. : 452-461

Bentham Science Publishers

Access to resources Recommend Favorite

Could Better Phenotyping Small Vessel Disease Provide New Insights into Alzheimer Disease and Improve Clinical Trial Outcomes?

By  

Current Alzheimer Research, Vol. 13, Iss. 7, 2016-07 ,pp. : 750-763

Bentham Science Publishers

Access to resources Recommend Favorite

The physical environment of the person with Alzheimer's disease

By Lawton M. Powell  

Aging and Mental Health, Vol. 5, Iss. 2, 2001-05 ,pp. : 56-64

Routledge Ltd

Access to resources Recommend Favorite

Does the clinical practice guideline on Parkinson’s disease change health outcomes? A cluster randomized controlled trial

By Larisch Astrid   Reuss Alexander   Oertel Wolfgang   Eggert Karla  

Journal of Neurology, Vol. 258, Iss. 5, 2011-05 ,pp. : 826-834

Springer Publishing Company

Access to resources Recommend Favorite